nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethacrynic acid—hypertension—type 2 diabetes mellitus	0.48	1	CtDrD
Ethacrynic acid—ALB—type 2 diabetes mellitus	0.107	1	CbGaD
Ethacrynic acid—ALB—Gliclazide—type 2 diabetes mellitus	0.0331	0.117	CbGbCtD
Ethacrynic acid—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.033	0.117	CbGbCtD
Ethacrynic acid—ALB—Repaglinide—type 2 diabetes mellitus	0.0311	0.11	CbGbCtD
Ethacrynic acid—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0294	0.104	CbGbCtD
Ethacrynic acid—ALB—Rosiglitazone—type 2 diabetes mellitus	0.026	0.0921	CbGbCtD
Ethacrynic acid—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.025	0.0888	CbGbCtD
Ethacrynic acid—ALB—Valsartan—type 2 diabetes mellitus	0.0229	0.0814	CbGbCtD
Ethacrynic acid—ALB—Nateglinide—type 2 diabetes mellitus	0.0213	0.0756	CbGbCtD
Ethacrynic acid—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0169	0.06	CbGbCtD
Ethacrynic acid—SLC22A6—Losartan—type 2 diabetes mellitus	0.0155	0.0549	CbGbCtD
Ethacrynic acid—ALB—Glyburide—type 2 diabetes mellitus	0.0144	0.0511	CbGbCtD
Ethacrynic acid—ALB—Losartan—type 2 diabetes mellitus	0.0132	0.0467	CbGbCtD
Ethacrynic acid—SLC12A1—nephron tubule—type 2 diabetes mellitus	0.000566	0.0761	CbGeAlD
Ethacrynic acid—GSTA2—cardiovascular system—type 2 diabetes mellitus	0.000559	0.0751	CbGeAlD
Ethacrynic acid—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000549	0.0738	CbGeAlD
Ethacrynic acid—GSTA2—kidney—type 2 diabetes mellitus	0.000547	0.0735	CbGeAlD
Ethacrynic acid—GSTA2—pancreas—type 2 diabetes mellitus	0.000543	0.073	CbGeAlD
Ethacrynic acid—SLC12A1—kidney—type 2 diabetes mellitus	0.000497	0.0669	CbGeAlD
Ethacrynic acid—SLC12A1—cortex of kidney—type 2 diabetes mellitus	0.000484	0.0651	CbGeAlD
Ethacrynic acid—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.00047	0.0632	CbGeAlD
Ethacrynic acid—ATP1A1—islet of Langerhans—type 2 diabetes mellitus	0.000409	0.055	CbGeAlD
Ethacrynic acid—ATP1A1—retina—type 2 diabetes mellitus	0.00035	0.047	CbGeAlD
Ethacrynic acid—GSTA2—liver—type 2 diabetes mellitus	0.000345	0.0465	CbGeAlD
Ethacrynic acid—ATP1A1—nephron tubule—type 2 diabetes mellitus	0.000329	0.0443	CbGeAlD
Ethacrynic acid—ATP1A1—cardiovascular system—type 2 diabetes mellitus	0.000296	0.0398	CbGeAlD
Ethacrynic acid—ATP1A1—kidney—type 2 diabetes mellitus	0.000289	0.0389	CbGeAlD
Ethacrynic acid—ATP1A1—pancreas—type 2 diabetes mellitus	0.000287	0.0387	CbGeAlD
Ethacrynic acid—ATP1A1—cortex of kidney—type 2 diabetes mellitus	0.000282	0.0379	CbGeAlD
Ethacrynic acid—ATP1A1—adipose tissue—type 2 diabetes mellitus	0.000261	0.0351	CbGeAlD
Ethacrynic acid—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000228	0.00275	CcSEcCtD
Ethacrynic acid—Anorexia—Glipizide—type 2 diabetes mellitus	0.000228	0.00274	CcSEcCtD
Ethacrynic acid—Neutropenia—Metformin—type 2 diabetes mellitus	0.000227	0.00273	CcSEcCtD
Ethacrynic acid—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000227	0.00273	CcSEcCtD
Ethacrynic acid—Rash—Tolazamide—type 2 diabetes mellitus	0.000227	0.00273	CcSEcCtD
Ethacrynic acid—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000226	0.00271	CcSEcCtD
Ethacrynic acid—Headache—Tolazamide—type 2 diabetes mellitus	0.000226	0.00271	CcSEcCtD
Ethacrynic acid—Confusional state—Glimepiride—type 2 diabetes mellitus	0.000225	0.0027	CcSEcCtD
Ethacrynic acid—Rash—Linagliptin—type 2 diabetes mellitus	0.000225	0.0027	CcSEcCtD
Ethacrynic acid—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000224	0.0027	CcSEcCtD
Ethacrynic acid—Headache—Linagliptin—type 2 diabetes mellitus	0.000223	0.00269	CcSEcCtD
Ethacrynic acid—Vertigo—Bromocriptine—type 2 diabetes mellitus	0.000221	0.00266	CcSEcCtD
Ethacrynic acid—Vomiting—Acarbose—type 2 diabetes mellitus	0.00022	0.00265	CcSEcCtD
Ethacrynic acid—Hypoglycaemia—Ramipril—type 2 diabetes mellitus	0.000219	0.00264	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.000218	0.00263	CcSEcCtD
Ethacrynic acid—Rash—Acarbose—type 2 diabetes mellitus	0.000218	0.00262	CcSEcCtD
Ethacrynic acid—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000218	0.00262	CcSEcCtD
Ethacrynic acid—Tinnitus—Gliclazide—type 2 diabetes mellitus	0.000217	0.00261	CcSEcCtD
Ethacrynic acid—Neutropenia—Irbesartan—type 2 diabetes mellitus	0.000214	0.00258	CcSEcCtD
Ethacrynic acid—Nausea—Tolazamide—type 2 diabetes mellitus	0.000214	0.00257	CcSEcCtD
Ethacrynic acid—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000214	0.00257	CcSEcCtD
Ethacrynic acid—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.000213	0.00257	CcSEcCtD
Ethacrynic acid—Anorexia—Glimepiride—type 2 diabetes mellitus	0.000212	0.00256	CcSEcCtD
Ethacrynic acid—Vision blurred—Glyburide—type 2 diabetes mellitus	0.000212	0.00255	CcSEcCtD
Ethacrynic acid—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000212	0.00255	CcSEcCtD
Ethacrynic acid—Rash—Nateglinide—type 2 diabetes mellitus	0.00021	0.00253	CcSEcCtD
Ethacrynic acid—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00021	0.00253	CcSEcCtD
Ethacrynic acid—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.000209	0.00252	CcSEcCtD
Ethacrynic acid—Chills—Gliclazide—type 2 diabetes mellitus	0.000208	0.00251	CcSEcCtD
Ethacrynic acid—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000208	0.0025	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Irbesartan—type 2 diabetes mellitus	0.000207	0.00249	CcSEcCtD
Ethacrynic acid—Nausea—Acarbose—type 2 diabetes mellitus	0.000205	0.00247	CcSEcCtD
Ethacrynic acid—Pain—Glipizide—type 2 diabetes mellitus	0.000204	0.00246	CcSEcCtD
Ethacrynic acid—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.000203	0.00244	CcSEcCtD
Ethacrynic acid—Jaundice—Irbesartan—type 2 diabetes mellitus	0.000199	0.0024	CcSEcCtD
Ethacrynic acid—Nausea—Nateglinide—type 2 diabetes mellitus	0.000198	0.00238	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Ramipril—type 2 diabetes mellitus	0.000198	0.00238	CcSEcCtD
Ethacrynic acid—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000197	0.00238	CcSEcCtD
Ethacrynic acid—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000197	0.00237	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000197	0.00237	CcSEcCtD
Ethacrynic acid—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000196	0.00236	CcSEcCtD
Ethacrynic acid—Convulsion—Glyburide—type 2 diabetes mellitus	0.000195	0.00235	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.000195	0.00234	CcSEcCtD
Ethacrynic acid—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000194	0.00233	CcSEcCtD
Ethacrynic acid—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000193	0.00232	CcSEcCtD
Ethacrynic acid—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000192	0.00231	CcSEcCtD
Ethacrynic acid—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000192	0.00231	CcSEcCtD
Ethacrynic acid—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000192	0.00231	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000191	0.00229	CcSEcCtD
Ethacrynic acid—Pain—Sitagliptin—type 2 diabetes mellitus	0.00019	0.00229	CcSEcCtD
Ethacrynic acid—ALB—liver—type 2 diabetes mellitus	0.00019	0.0255	CbGeAlD
Ethacrynic acid—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000189	0.00227	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.000188	0.00226	CcSEcCtD
Ethacrynic acid—Jaundice—Losartan—type 2 diabetes mellitus	0.000187	0.00226	CcSEcCtD
Ethacrynic acid—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000187	0.00225	CcSEcCtD
Ethacrynic acid—Confusional state—Glyburide—type 2 diabetes mellitus	0.000185	0.00223	CcSEcCtD
Ethacrynic acid—Dysphagia—Ramipril—type 2 diabetes mellitus	0.000185	0.00223	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000184	0.00221	CcSEcCtD
Ethacrynic acid—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000184	0.00221	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000183	0.0022	CcSEcCtD
Ethacrynic acid—ATP1A1—liver—type 2 diabetes mellitus	0.000183	0.0246	CbGeAlD
Ethacrynic acid—Malaise—Gliclazide—type 2 diabetes mellitus	0.000182	0.00219	CcSEcCtD
Ethacrynic acid—Rash—Repaglinide—type 2 diabetes mellitus	0.000182	0.00219	CcSEcCtD
Ethacrynic acid—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000182	0.00219	CcSEcCtD
Ethacrynic acid—Headache—Repaglinide—type 2 diabetes mellitus	0.000181	0.00218	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.00018	0.00217	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000179	0.00216	CcSEcCtD
Ethacrynic acid—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.000177	0.00213	CcSEcCtD
Ethacrynic acid—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000175	0.00211	CcSEcCtD
Ethacrynic acid—Anorexia—Glyburide—type 2 diabetes mellitus	0.000175	0.00211	CcSEcCtD
Ethacrynic acid—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000175	0.00211	CcSEcCtD
Ethacrynic acid—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000175	0.0021	CcSEcCtD
Ethacrynic acid—Chills—Metformin—type 2 diabetes mellitus	0.000174	0.0021	CcSEcCtD
Ethacrynic acid—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000173	0.00209	CcSEcCtD
Ethacrynic acid—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000173	0.00208	CcSEcCtD
Ethacrynic acid—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000173	0.00208	CcSEcCtD
Ethacrynic acid—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000172	0.00207	CcSEcCtD
Ethacrynic acid—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000172	0.00207	CcSEcCtD
Ethacrynic acid—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000172	0.00207	CcSEcCtD
Ethacrynic acid—Nausea—Repaglinide—type 2 diabetes mellitus	0.000171	0.00206	CcSEcCtD
Ethacrynic acid—Asthenia—Glipizide—type 2 diabetes mellitus	0.000171	0.00206	CcSEcCtD
Ethacrynic acid—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000171	0.00206	CcSEcCtD
Ethacrynic acid—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000171	0.00206	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.00017	0.00205	CcSEcCtD
Ethacrynic acid—Discomfort—Gliclazide—type 2 diabetes mellitus	0.00017	0.00205	CcSEcCtD
Ethacrynic acid—Vertigo—Valsartan—type 2 diabetes mellitus	0.000167	0.00201	CcSEcCtD
Ethacrynic acid—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000166	0.002	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000166	0.00199	CcSEcCtD
Ethacrynic acid—Malaise—Orlistat—type 2 diabetes mellitus	0.000166	0.00199	CcSEcCtD
Ethacrynic acid—Vertigo—Orlistat—type 2 diabetes mellitus	0.000165	0.00199	CcSEcCtD
Ethacrynic acid—Chills—Irbesartan—type 2 diabetes mellitus	0.000165	0.00198	CcSEcCtD
Ethacrynic acid—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000164	0.00198	CcSEcCtD
Ethacrynic acid—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000163	0.00197	CcSEcCtD
Ethacrynic acid—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000162	0.00195	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000162	0.00194	CcSEcCtD
Ethacrynic acid—Tinnitus—Losartan—type 2 diabetes mellitus	0.000161	0.00194	CcSEcCtD
Ethacrynic acid—Jaundice—Ramipril—type 2 diabetes mellitus	0.000161	0.00193	CcSEcCtD
Ethacrynic acid—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00016	0.00192	CcSEcCtD
Ethacrynic acid—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.00016	0.00192	CcSEcCtD
Ethacrynic acid—Vision blurred—Metformin—type 2 diabetes mellitus	0.000159	0.00192	CcSEcCtD
Ethacrynic acid—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000159	0.00192	CcSEcCtD
Ethacrynic acid—Convulsion—Orlistat—type 2 diabetes mellitus	0.000159	0.00191	CcSEcCtD
Ethacrynic acid—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000159	0.00191	CcSEcCtD
Ethacrynic acid—Anxiety—Valsartan—type 2 diabetes mellitus	0.000158	0.0019	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000157	0.00189	CcSEcCtD
Ethacrynic acid—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000157	0.00188	CcSEcCtD
Ethacrynic acid—Anxiety—Orlistat—type 2 diabetes mellitus	0.000156	0.00187	CcSEcCtD
Ethacrynic acid—Discomfort—Orlistat—type 2 diabetes mellitus	0.000154	0.00186	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000154	0.00185	CcSEcCtD
Ethacrynic acid—Malaise—Metformin—type 2 diabetes mellitus	0.000153	0.00184	CcSEcCtD
Ethacrynic acid—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000152	0.00184	CcSEcCtD
Ethacrynic acid—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000152	0.00183	CcSEcCtD
Ethacrynic acid—Vomiting—Glipizide—type 2 diabetes mellitus	0.000152	0.00183	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000151	0.00182	CcSEcCtD
Ethacrynic acid—Rash—Glipizide—type 2 diabetes mellitus	0.000151	0.00181	CcSEcCtD
Ethacrynic acid—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.00015	0.00181	CcSEcCtD
Ethacrynic acid—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00015	0.00181	CcSEcCtD
Ethacrynic acid—Headache—Glipizide—type 2 diabetes mellitus	0.00015	0.0018	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000148	0.00179	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000148	0.00178	CcSEcCtD
Ethacrynic acid—Anorexia—Valsartan—type 2 diabetes mellitus	0.000145	0.00174	CcSEcCtD
Ethacrynic acid—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000144	0.00174	CcSEcCtD
Ethacrynic acid—Malaise—Irbesartan—type 2 diabetes mellitus	0.000144	0.00173	CcSEcCtD
Ethacrynic acid—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000143	0.00173	CcSEcCtD
Ethacrynic acid—Headache—Pioglitazone—type 2 diabetes mellitus	0.000143	0.00173	CcSEcCtD
Ethacrynic acid—Discomfort—Metformin—type 2 diabetes mellitus	0.000142	0.00171	CcSEcCtD
Ethacrynic acid—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000142	0.00171	CcSEcCtD
Ethacrynic acid—Nausea—Glipizide—type 2 diabetes mellitus	0.000142	0.00171	CcSEcCtD
Ethacrynic acid—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000142	0.00171	CcSEcCtD
Ethacrynic acid—Vision blurred—Losartan—type 2 diabetes mellitus	0.000142	0.0017	CcSEcCtD
Ethacrynic acid—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000141	0.0017	CcSEcCtD
Ethacrynic acid—Pain—Gliclazide—type 2 diabetes mellitus	0.000141	0.0017	CcSEcCtD
Ethacrynic acid—Rash—Glimepiride—type 2 diabetes mellitus	0.000141	0.00169	CcSEcCtD
Ethacrynic acid—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00014	0.00169	CcSEcCtD
Ethacrynic acid—Rash—Sitagliptin—type 2 diabetes mellitus	0.00014	0.00169	CcSEcCtD
Ethacrynic acid—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00014	0.00168	CcSEcCtD
Ethacrynic acid—Headache—Glimepiride—type 2 diabetes mellitus	0.00014	0.00168	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000139	0.00168	CcSEcCtD
Ethacrynic acid—Headache—Sitagliptin—type 2 diabetes mellitus	0.000139	0.00168	CcSEcCtD
Ethacrynic acid—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000138	0.00166	CcSEcCtD
Ethacrynic acid—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000138	0.00166	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000136	0.00164	CcSEcCtD
Ethacrynic acid—Malaise—Losartan—type 2 diabetes mellitus	0.000136	0.00163	CcSEcCtD
Ethacrynic acid—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000135	0.00163	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000135	0.00163	CcSEcCtD
Ethacrynic acid—Vertigo—Losartan—type 2 diabetes mellitus	0.000135	0.00162	CcSEcCtD
Ethacrynic acid—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000134	0.00162	CcSEcCtD
Ethacrynic acid—Nausea—Glimepiride—type 2 diabetes mellitus	0.000132	0.00159	CcSEcCtD
Ethacrynic acid—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000132	0.00159	CcSEcCtD
Ethacrynic acid—Asthenia—Glyburide—type 2 diabetes mellitus	0.000132	0.00159	CcSEcCtD
Ethacrynic acid—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000132	0.00159	CcSEcCtD
Ethacrynic acid—Anorexia—Metformin—type 2 diabetes mellitus	0.000132	0.00158	CcSEcCtD
Ethacrynic acid—Fatigue—Valsartan—type 2 diabetes mellitus	0.000131	0.00157	CcSEcCtD
Ethacrynic acid—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00013	0.00157	CcSEcCtD
Ethacrynic acid—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00013	0.00157	CcSEcCtD
Ethacrynic acid—Fatigue—Orlistat—type 2 diabetes mellitus	0.000129	0.00155	CcSEcCtD
Ethacrynic acid—Pain—Orlistat—type 2 diabetes mellitus	0.000128	0.00154	CcSEcCtD
Ethacrynic acid—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000128	0.00154	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000128	0.00154	CcSEcCtD
Ethacrynic acid—Anxiety—Losartan—type 2 diabetes mellitus	0.000127	0.00153	CcSEcCtD
Ethacrynic acid—Rash—Bromocriptine—type 2 diabetes mellitus	0.000127	0.00153	CcSEcCtD
Ethacrynic acid—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000127	0.00152	CcSEcCtD
Ethacrynic acid—Discomfort—Losartan—type 2 diabetes mellitus	0.000126	0.00152	CcSEcCtD
Ethacrynic acid—Headache—Bromocriptine—type 2 diabetes mellitus	0.000126	0.00152	CcSEcCtD
Ethacrynic acid—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000126	0.00151	CcSEcCtD
Ethacrynic acid—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000124	0.0015	CcSEcCtD
Ethacrynic acid—Confusional state—Losartan—type 2 diabetes mellitus	0.000124	0.00149	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000123	0.00149	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.00012	0.00145	CcSEcCtD
Ethacrynic acid—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00012	0.00144	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.00012	0.00144	CcSEcCtD
Ethacrynic acid—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000119	0.00144	CcSEcCtD
Ethacrynic acid—Fatigue—Metformin—type 2 diabetes mellitus	0.000119	0.00143	CcSEcCtD
Ethacrynic acid—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000118	0.00143	CcSEcCtD
Ethacrynic acid—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000118	0.00143	CcSEcCtD
Ethacrynic acid—Anorexia—Losartan—type 2 diabetes mellitus	0.000117	0.00141	CcSEcCtD
Ethacrynic acid—Vomiting—Glyburide—type 2 diabetes mellitus	0.000117	0.00141	CcSEcCtD
Ethacrynic acid—Malaise—Ramipril—type 2 diabetes mellitus	0.000116	0.0014	CcSEcCtD
Ethacrynic acid—Rash—Glyburide—type 2 diabetes mellitus	0.000116	0.00139	CcSEcCtD
Ethacrynic acid—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000116	0.00139	CcSEcCtD
Ethacrynic acid—Vertigo—Ramipril—type 2 diabetes mellitus	0.000116	0.00139	CcSEcCtD
Ethacrynic acid—Headache—Glyburide—type 2 diabetes mellitus	0.000115	0.00139	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000114	0.00137	CcSEcCtD
Ethacrynic acid—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000113	0.00136	CcSEcCtD
Ethacrynic acid—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000113	0.00136	CcSEcCtD
Ethacrynic acid—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000112	0.00135	CcSEcCtD
Ethacrynic acid—Convulsion—Ramipril—type 2 diabetes mellitus	0.000112	0.00134	CcSEcCtD
Ethacrynic acid—Pain—Irbesartan—type 2 diabetes mellitus	0.000111	0.00134	CcSEcCtD
Ethacrynic acid—Anxiety—Ramipril—type 2 diabetes mellitus	0.000109	0.00132	CcSEcCtD
Ethacrynic acid—Nausea—Glyburide—type 2 diabetes mellitus	0.000109	0.00131	CcSEcCtD
Ethacrynic acid—Asthenia—Valsartan—type 2 diabetes mellitus	0.000109	0.00131	CcSEcCtD
Ethacrynic acid—Discomfort—Ramipril—type 2 diabetes mellitus	0.000108	0.0013	CcSEcCtD
Ethacrynic acid—Asthenia—Orlistat—type 2 diabetes mellitus	0.000107	0.00129	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000107	0.00129	CcSEcCtD
Ethacrynic acid—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000107	0.00128	CcSEcCtD
Ethacrynic acid—Confusional state—Ramipril—type 2 diabetes mellitus	0.000106	0.00128	CcSEcCtD
Ethacrynic acid—Fatigue—Losartan—type 2 diabetes mellitus	0.000106	0.00127	CcSEcCtD
Ethacrynic acid—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000105	0.00126	CcSEcCtD
Ethacrynic acid—Pain—Losartan—type 2 diabetes mellitus	0.000105	0.00126	CcSEcCtD
Ethacrynic acid—Rash—Gliclazide—type 2 diabetes mellitus	0.000104	0.00125	CcSEcCtD
Ethacrynic acid—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000104	0.00125	CcSEcCtD
Ethacrynic acid—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000104	0.00125	CcSEcCtD
Ethacrynic acid—Headache—Gliclazide—type 2 diabetes mellitus	0.000103	0.00124	CcSEcCtD
Ethacrynic acid—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000103	0.00124	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000103	0.00124	CcSEcCtD
Ethacrynic acid—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000103	0.00123	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000101	0.00122	CcSEcCtD
Ethacrynic acid—Anorexia—Ramipril—type 2 diabetes mellitus	0.0001	0.00121	CcSEcCtD
Ethacrynic acid—Asthenia—Metformin—type 2 diabetes mellitus	9.91e-05	0.00119	CcSEcCtD
Ethacrynic acid—Nausea—Gliclazide—type 2 diabetes mellitus	9.8e-05	0.00118	CcSEcCtD
Ethacrynic acid—Body temperature increased—Losartan—type 2 diabetes mellitus	9.69e-05	0.00117	CcSEcCtD
Ethacrynic acid—Vomiting—Valsartan—type 2 diabetes mellitus	9.64e-05	0.00116	CcSEcCtD
Ethacrynic acid—Rash—Valsartan—type 2 diabetes mellitus	9.56e-05	0.00115	CcSEcCtD
Ethacrynic acid—Dermatitis—Valsartan—type 2 diabetes mellitus	9.55e-05	0.00115	CcSEcCtD
Ethacrynic acid—Vomiting—Orlistat—type 2 diabetes mellitus	9.53e-05	0.00115	CcSEcCtD
Ethacrynic acid—Headache—Valsartan—type 2 diabetes mellitus	9.5e-05	0.00114	CcSEcCtD
Ethacrynic acid—Diarrhoea—Metformin—type 2 diabetes mellitus	9.45e-05	0.00114	CcSEcCtD
Ethacrynic acid—Rash—Orlistat—type 2 diabetes mellitus	9.45e-05	0.00114	CcSEcCtD
Ethacrynic acid—Dermatitis—Orlistat—type 2 diabetes mellitus	9.44e-05	0.00114	CcSEcCtD
Ethacrynic acid—Headache—Orlistat—type 2 diabetes mellitus	9.39e-05	0.00113	CcSEcCtD
Ethacrynic acid—Asthenia—Irbesartan—type 2 diabetes mellitus	9.35e-05	0.00113	CcSEcCtD
Ethacrynic acid—Decreased appetite—Ramipril—type 2 diabetes mellitus	9.14e-05	0.0011	CcSEcCtD
Ethacrynic acid—Fatigue—Ramipril—type 2 diabetes mellitus	9.07e-05	0.00109	CcSEcCtD
Ethacrynic acid—Nausea—Valsartan—type 2 diabetes mellitus	9.01e-05	0.00108	CcSEcCtD
Ethacrynic acid—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.92e-05	0.00107	CcSEcCtD
Ethacrynic acid—Nausea—Orlistat—type 2 diabetes mellitus	8.9e-05	0.00107	CcSEcCtD
Ethacrynic acid—Asthenia—Losartan—type 2 diabetes mellitus	8.8e-05	0.00106	CcSEcCtD
Ethacrynic acid—Vomiting—Metformin—type 2 diabetes mellitus	8.78e-05	0.00106	CcSEcCtD
Ethacrynic acid—Rash—Metformin—type 2 diabetes mellitus	8.71e-05	0.00105	CcSEcCtD
Ethacrynic acid—Dermatitis—Metformin—type 2 diabetes mellitus	8.7e-05	0.00105	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8.67e-05	0.00104	CcSEcCtD
Ethacrynic acid—Headache—Metformin—type 2 diabetes mellitus	8.65e-05	0.00104	CcSEcCtD
Ethacrynic acid—Diarrhoea—Losartan—type 2 diabetes mellitus	8.39e-05	0.00101	CcSEcCtD
Ethacrynic acid—Body temperature increased—Ramipril—type 2 diabetes mellitus	8.31e-05	0.001	CcSEcCtD
Ethacrynic acid—Vomiting—Irbesartan—type 2 diabetes mellitus	8.29e-05	0.000997	CcSEcCtD
Ethacrynic acid—Rash—Irbesartan—type 2 diabetes mellitus	8.22e-05	0.000989	CcSEcCtD
Ethacrynic acid—Dermatitis—Irbesartan—type 2 diabetes mellitus	8.21e-05	0.000988	CcSEcCtD
Ethacrynic acid—Nausea—Metformin—type 2 diabetes mellitus	8.2e-05	0.000987	CcSEcCtD
Ethacrynic acid—Headache—Irbesartan—type 2 diabetes mellitus	8.16e-05	0.000983	CcSEcCtD
Ethacrynic acid—Vomiting—Losartan—type 2 diabetes mellitus	7.8e-05	0.000939	CcSEcCtD
Ethacrynic acid—Nausea—Irbesartan—type 2 diabetes mellitus	7.74e-05	0.000932	CcSEcCtD
Ethacrynic acid—Rash—Losartan—type 2 diabetes mellitus	7.73e-05	0.000931	CcSEcCtD
Ethacrynic acid—Dermatitis—Losartan—type 2 diabetes mellitus	7.73e-05	0.00093	CcSEcCtD
Ethacrynic acid—Headache—Losartan—type 2 diabetes mellitus	7.68e-05	0.000925	CcSEcCtD
Ethacrynic acid—Asthenia—Ramipril—type 2 diabetes mellitus	7.54e-05	0.000908	CcSEcCtD
Ethacrynic acid—Nausea—Losartan—type 2 diabetes mellitus	7.28e-05	0.000877	CcSEcCtD
Ethacrynic acid—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.19e-05	0.000866	CcSEcCtD
Ethacrynic acid—Vomiting—Ramipril—type 2 diabetes mellitus	6.69e-05	0.000805	CcSEcCtD
Ethacrynic acid—Rash—Ramipril—type 2 diabetes mellitus	6.63e-05	0.000798	CcSEcCtD
Ethacrynic acid—Dermatitis—Ramipril—type 2 diabetes mellitus	6.62e-05	0.000797	CcSEcCtD
Ethacrynic acid—Headache—Ramipril—type 2 diabetes mellitus	6.59e-05	0.000793	CcSEcCtD
Ethacrynic acid—Nausea—Ramipril—type 2 diabetes mellitus	6.25e-05	0.000752	CcSEcCtD
Ethacrynic acid—ALB—Selenium Micronutrient Network—SERPINE1—type 2 diabetes mellitus	2.48e-05	0.000601	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	2.48e-05	0.000601	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	2.48e-05	0.000601	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	2.46e-05	0.000597	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	2.45e-05	0.000594	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.43e-05	0.00059	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.43e-05	0.000589	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	2.42e-05	0.000586	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—NFKB1—type 2 diabetes mellitus	2.37e-05	0.000574	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	2.36e-05	0.000572	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.33e-05	0.000566	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP1A2—type 2 diabetes mellitus	2.31e-05	0.000559	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.31e-05	0.000559	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	2.31e-05	0.000559	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	2.31e-05	0.000559	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	2.31e-05	0.000559	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PTPN1—type 2 diabetes mellitus	2.3e-05	0.000558	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—RASGRP1—type 2 diabetes mellitus	2.26e-05	0.000549	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—TNF—type 2 diabetes mellitus	2.26e-05	0.000549	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.25e-05	0.000545	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—RELA—type 2 diabetes mellitus	2.23e-05	0.00054	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.21e-05	0.000536	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GCG—type 2 diabetes mellitus	2.21e-05	0.000536	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—PTGS2—type 2 diabetes mellitus	2.17e-05	0.000525	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	2.16e-05	0.000524	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ATP2A3—type 2 diabetes mellitus	2.12e-05	0.000515	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.11e-05	0.000511	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.1e-05	0.00051	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.1e-05	0.00051	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	2.09e-05	0.000507	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2.06e-05	0.000499	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	2.06e-05	0.000498	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—SOD1—type 2 diabetes mellitus	2.05e-05	0.000497	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.02e-05	0.000491	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.02e-05	0.000491	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.02e-05	0.00049	CbGpPWpGaD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	2e-05	0.000485	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	1.99e-05	0.000482	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—GNB3—type 2 diabetes mellitus	1.98e-05	0.000481	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.97e-05	0.000479	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IGF2—type 2 diabetes mellitus	1.95e-05	0.000472	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.91e-05	0.000462	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GNB3—type 2 diabetes mellitus	1.91e-05	0.000462	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—HMOX1—type 2 diabetes mellitus	1.9e-05	0.00046	CbGpPWpGaD
Ethacrynic acid—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	1.9e-05	0.00046	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—NFKB1—type 2 diabetes mellitus	1.88e-05	0.000456	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CAT—type 2 diabetes mellitus	1.87e-05	0.000454	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—VEGFA—type 2 diabetes mellitus	1.84e-05	0.000446	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—TNF—type 2 diabetes mellitus	1.84e-05	0.000446	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	1.84e-05	0.000445	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—IL6—type 2 diabetes mellitus	1.83e-05	0.000443	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—APOB—type 2 diabetes mellitus	1.82e-05	0.000441	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—THBD—type 2 diabetes mellitus	1.8e-05	0.000438	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTM1—type 2 diabetes mellitus	1.77e-05	0.000429	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—type 2 diabetes mellitus	1.75e-05	0.000425	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	1.75e-05	0.000424	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	1.75e-05	0.000424	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—LPL—type 2 diabetes mellitus	1.74e-05	0.000421	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.72e-05	0.000417	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	1.72e-05	0.000416	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—CD36—type 2 diabetes mellitus	1.72e-05	0.000416	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—BHMT—type 2 diabetes mellitus	1.71e-05	0.000416	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.7e-05	0.000413	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ADCY5—type 2 diabetes mellitus	1.7e-05	0.000412	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.69e-05	0.000411	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GPX1—type 2 diabetes mellitus	1.69e-05	0.000411	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—TGFB1—type 2 diabetes mellitus	1.69e-05	0.00041	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.68e-05	0.000407	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.66e-05	0.000403	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CD36—type 2 diabetes mellitus	1.65e-05	0.0004	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.63e-05	0.000395	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.62e-05	0.000394	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—type 2 diabetes mellitus	1.61e-05	0.00039	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.59e-05	0.000386	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—MTHFR—type 2 diabetes mellitus	1.56e-05	0.000379	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PPARA—type 2 diabetes mellitus	1.53e-05	0.000372	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ATP2A2—type 2 diabetes mellitus	1.52e-05	0.00037	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—CALM1—type 2 diabetes mellitus	1.52e-05	0.000368	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.52e-05	0.000368	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTGDS—type 2 diabetes mellitus	1.5e-05	0.000363	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—AANAT—type 2 diabetes mellitus	1.5e-05	0.000363	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—APOA1—type 2 diabetes mellitus	1.5e-05	0.000363	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—IL6—type 2 diabetes mellitus	1.49e-05	0.00036	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—AGT—type 2 diabetes mellitus	1.48e-05	0.00036	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TRPC6—type 2 diabetes mellitus	1.48e-05	0.000359	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	1.46e-05	0.000355	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CALM1—type 2 diabetes mellitus	1.46e-05	0.000354	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—F7—type 2 diabetes mellitus	1.45e-05	0.000353	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—APOE—type 2 diabetes mellitus	1.45e-05	0.000353	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—APOA1—type 2 diabetes mellitus	1.44e-05	0.000349	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PRKCB—type 2 diabetes mellitus	1.43e-05	0.000346	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.42e-05	0.000345	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CDO1—type 2 diabetes mellitus	1.42e-05	0.000344	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GPD2—type 2 diabetes mellitus	1.42e-05	0.000344	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.39e-05	0.000337	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.38e-05	0.000335	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.38e-05	0.000335	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.37e-05	0.000332	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—AK1—type 2 diabetes mellitus	1.35e-05	0.000329	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.34e-05	0.000325	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.32e-05	0.00032	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.32e-05	0.00032	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ADRA2A—type 2 diabetes mellitus	1.3e-05	0.000316	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PLAT—type 2 diabetes mellitus	1.3e-05	0.000314	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TIMP1—type 2 diabetes mellitus	1.3e-05	0.000314	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.29e-05	0.000312	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.28e-05	0.000311	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.28e-05	0.000311	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.27e-05	0.000309	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PPARG—type 2 diabetes mellitus	1.27e-05	0.000307	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—MAT1A—type 2 diabetes mellitus	1.25e-05	0.000303	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC5A4—type 2 diabetes mellitus	1.25e-05	0.000303	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IGF1—type 2 diabetes mellitus	1.25e-05	0.000303	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—AKT2—type 2 diabetes mellitus	1.25e-05	0.000303	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.25e-05	0.000302	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—INS—type 2 diabetes mellitus	1.24e-05	0.000301	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.22e-05	0.000296	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—NOS1—type 2 diabetes mellitus	1.22e-05	0.000296	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.21e-05	0.000294	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ENPP1—type 2 diabetes mellitus	1.21e-05	0.000293	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—G6PC—type 2 diabetes mellitus	1.21e-05	0.000293	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HBA2—type 2 diabetes mellitus	1.21e-05	0.000293	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ND1—type 2 diabetes mellitus	1.21e-05	0.000293	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.21e-05	0.000293	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—SERPINE1—type 2 diabetes mellitus	1.19e-05	0.000288	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PTPN1—type 2 diabetes mellitus	1.19e-05	0.000288	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	1.18e-05	0.000286	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GCGR—type 2 diabetes mellitus	1.17e-05	0.000284	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—RASGRP1—type 2 diabetes mellitus	1.17e-05	0.000283	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ALB—type 2 diabetes mellitus	1.14e-05	0.000276	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3R1—type 2 diabetes mellitus	1.13e-05	0.000275	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	1.13e-05	0.000273	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.12e-05	0.000272	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYTB—type 2 diabetes mellitus	1.1e-05	0.000268	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—OXCT1—type 2 diabetes mellitus	1.1e-05	0.000268	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—NOS3—type 2 diabetes mellitus	1.09e-05	0.000264	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.09e-05	0.000264	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SRD5A1—type 2 diabetes mellitus	1.08e-05	0.000261	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.07e-05	0.00026	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SOD1—type 2 diabetes mellitus	1.06e-05	0.000256	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—STAR—type 2 diabetes mellitus	1.03e-05	0.000249	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ACACA—type 2 diabetes mellitus	1.03e-05	0.000249	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HSD17B3—type 2 diabetes mellitus	1.03e-05	0.000249	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.03e-05	0.000249	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—GNB3—type 2 diabetes mellitus	1.02e-05	0.000248	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.02e-05	0.000247	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IGF2—type 2 diabetes mellitus	1e-05	0.000243	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PTGS2—type 2 diabetes mellitus	9.97e-06	0.000242	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CBS—type 2 diabetes mellitus	9.85e-06	0.000239	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ABCC8—type 2 diabetes mellitus	9.85e-06	0.000239	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—APOB—type 2 diabetes mellitus	9.75e-06	0.000236	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—COX2—type 2 diabetes mellitus	9.48e-06	0.00023	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC5A2—type 2 diabetes mellitus	9.48e-06	0.00023	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NCOA6—type 2 diabetes mellitus	9.31e-06	0.000226	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	9.3e-06	0.000226	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—UCP3—type 2 diabetes mellitus	9.15e-06	0.000222	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—UCP2—type 2 diabetes mellitus	9.15e-06	0.000222	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HSD11B1—type 2 diabetes mellitus	9.15e-06	0.000222	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	8.87e-06	0.000215	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	8.85e-06	0.000215	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CD36—type 2 diabetes mellitus	8.84e-06	0.000214	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	8.81e-06	0.000214	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	8.73e-06	0.000212	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	8.73e-06	0.000212	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PCK1—type 2 diabetes mellitus	8.61e-06	0.000209	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	8.47e-06	0.000205	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	8.44e-06	0.000205	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	8.39e-06	0.000203	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	8.26e-06	0.0002	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	8.17e-06	0.000198	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	8.06e-06	0.000195	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HK1—type 2 diabetes mellitus	8.06e-06	0.000195	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	8.05e-06	0.000195	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	7.89e-06	0.000191	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	7.83e-06	0.00019	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	7.78e-06	0.000189	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	7.78e-06	0.000189	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—LPA—type 2 diabetes mellitus	7.78e-06	0.000189	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GCKR—type 2 diabetes mellitus	7.78e-06	0.000189	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	7.71e-06	0.000187	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	7.5e-06	0.000182	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	7.48e-06	0.000181	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	7.46e-06	0.000181	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	7.36e-06	0.000178	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	7.27e-06	0.000176	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.25e-06	0.000176	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.12e-06	0.000173	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.1e-06	0.000172	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.02e-06	0.00017	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	6.94e-06	0.000168	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.67e-06	0.000162	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	6.48e-06	0.000157	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	6.45e-06	0.000156	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	6.44e-06	0.000156	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	6.34e-06	0.000154	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—MTR—type 2 diabetes mellitus	6.34e-06	0.000154	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	6.22e-06	0.000151	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.19e-06	0.00015	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GCK—type 2 diabetes mellitus	6.18e-06	0.00015	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HBA1—type 2 diabetes mellitus	6.18e-06	0.00015	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—LIPC—type 2 diabetes mellitus	6.18e-06	0.00015	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	6.14e-06	0.000149	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	6.12e-06	0.000148	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	6.03e-06	0.000146	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CETP—type 2 diabetes mellitus	5.96e-06	0.000145	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	5.84e-06	0.000142	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	5.84e-06	0.000142	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	5.55e-06	0.000134	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	5.55e-06	0.000134	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	5.55e-06	0.000134	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CTGF—type 2 diabetes mellitus	5.44e-06	0.000132	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	5.39e-06	0.000131	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.32e-06	0.000129	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	5.28e-06	0.000128	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	5.21e-06	0.000126	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	5.07e-06	0.000123	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	5.01e-06	0.000122	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	5.01e-06	0.000122	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—AKT1—type 2 diabetes mellitus	5.01e-06	0.000121	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	4.89e-06	0.000119	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.87e-06	0.000118	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GCG—type 2 diabetes mellitus	4.81e-06	0.000117	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	4.81e-06	0.000117	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SRC—type 2 diabetes mellitus	4.32e-06	0.000105	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	4.21e-06	0.000102	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.14e-06	0.0001	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GNB3—type 2 diabetes mellitus	4.14e-06	0.0001	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	4.12e-06	0.0001	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CAT—type 2 diabetes mellitus	4.07e-06	9.87e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—APOB—type 2 diabetes mellitus	3.95e-06	9.58e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	3.86e-06	9.37e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	3.84e-06	9.32e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—LPL—type 2 diabetes mellitus	3.77e-06	9.15e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	3.69e-06	8.96e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GPX1—type 2 diabetes mellitus	3.68e-06	8.92e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CD36—type 2 diabetes mellitus	3.58e-06	8.69e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	3.54e-06	8.58e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	3.4e-06	8.24e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PPARA—type 2 diabetes mellitus	3.33e-06	8.08e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—AGT—type 2 diabetes mellitus	3.23e-06	7.83e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CALM1—type 2 diabetes mellitus	3.17e-06	7.69e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—APOE—type 2 diabetes mellitus	3.16e-06	7.67e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—APOA1—type 2 diabetes mellitus	3.13e-06	7.58e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PPARG—type 2 diabetes mellitus	2.75e-06	6.68e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—INS—type 2 diabetes mellitus	2.7e-06	6.55e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	2.69e-06	6.51e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	2.37e-06	5.74e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NOS3—type 2 diabetes mellitus	2.37e-06	5.74e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	2.17e-06	5.25e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.09e-06	2.64e-05	CbGpPWpGaD
